Morehouse School of Medicine-Neuroscience Institute

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Morehouse School of Medicine-Neuroscience Institute Receives a Five Million Dollar Award

ATLANTA, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Morehouse School of Medicine has received a five-year five million dollar (direct costs) Specialized Neuroscience Research Program (SNRP) award to fund cutting-edge, National Institute of Neurological Disorders and Stroke NINDS mission-related research performed by established investigators and early stage investigators in the Neuroscience Institute. Training of graduate students and postdoctoral fellows is a paramount goal of the program.

"Our program encourages the support of the Specialized Neuroscience Research Program initiative to institutions like MSM," said Dr. Courtney Ferrell-Aklin, NINDS program director for office of special programs in diversity. "We embrace their commitment to increasing academic scholarship and diversity in the neuroscience workforce."

The award, the only one made within the continental USA, supports research in discovery and the application of knowledge in basic and translational neuroscience to treating neurological disorders. Such support from the SNRP is designed to facilitate the planning, implementation and evaluation of meritorious exploratory research. It also expected to stimulates effective collaboration among academic research organizations and individuals conducting NINDS mission relevant research, while increasing the academic preparedness of students from diverse backgrounds for advanced neuroscience research careers.

"We were very fortunate to have the complete buy-in of all members of the Neuroscience Institute and full institutional support in preparing the application," said Dr. Peter MacLeish, chairman of the department of neurobiology, director of the Neuroscience Institute and SNRP Principal Investigator.

A key feature of the SNRP award is the establishment of a collaborative BS/MS degree program in neuroscience among MSM and three undergraduate institutions in the Atlanta University Center (AUC) , including Morehouse College, Spelman College and Clark-Atlanta University. The first cohort of students will be recruited and enrolled in the program during the spring of 2014.

"Morehouse School of Medicine recognizes the challenges set forth by the National Institute of Neurological Disorders and Stroke to advance the mission of NINDS and to play a major role in diversifying the scientific workforce," said Dr. Valerie Montgomery-Rice, dean and executive vice president at MSM. "MSM is committed to the support of the Neuroscience Institute, which has become a biomedical research performance model."

To learn more about the Neuroscience Institute and research programs click here .

About Morehouse School of Medicine (MSM)

Morehouse School of Medicine (MSM) was founded in 1975 in Atlanta, Georgia, as a two-year medical education program at Morehouse College, with clinical training affiliations with several established medical schools for awarding the M.D. degree. In 1981, MSM became an independently chartered institution and the first medical school established at a Historically Black College and University in the 20th century. MSM is among the nation's leading educators of primary care physicians and was recently recognized as the top institution among U.S. medical schools for our social mission. Our faculty and alumni are noted for excellence in teaching, research and public policy, as well as exceptional patient care.

Morehouse School of Medicine is accredited by the Commission on Colleges of the Southern Association of Colleges and Schools to award doctorate and master's degrees. 

Ronna Charles Nu'Man (404) 752-1717 Morehouse School of Medicine

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 3

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Resilience: From Trauma to Shielding Powerhouses

Updated Category News Views 6

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 4

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Camel Group Expands Battery Portfolio at Canton Fair

Updated Category News Views 3

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 1

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Encompass Health Expands With Texas Rehab Hospital

Updated Category News Views 6

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 3

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 1

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 6

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 0

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
iv>